Peer Review History
| Original SubmissionDecember 15, 2021 |
|---|
|
PONE-D-21-39637Passive epidemiological surveillance in wildlife in Costa Rica identifies pathogens of zoonotic and conservation importancePLOS ONE Dear Dr. Alfaro-Alarcon, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== Both reviewers note a disconnect between the stated aims of the paper (to evaluate the feasibility of implementing a passive surveillance system) and the actual content of the paper (results of pathological findings and their relevance for conservation/public health). Both reviewers in turn suggest the authors provide substantially more attention to a forward-looking component of their manuscript and propose concrete recommendations to implement such a program and how to make it sustainable/reproducible (one reviewer also suggests that the manuscript would greatly benefit from a flowchart of methodologies). Both reviewers also provide a number of more minor suggestions to improve clarity and precision of the manuscript. Some important clarifying points are also noted about inclusion/exclusion criteria for animals from rescue centers, given the possibility for pathogen exposure within the centers themselves (rather than from the forests).============================== Please submit your revised manuscript by May 14 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Daniel Becker Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that Figure 3 in your submission contain map images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright. We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission: 1. You may seek permission from the original copyright holder of Figure 3 to publish the content specifically under the CC BY 4.0 license. We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text: “I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.” Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission. In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].” 2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only. The following resources for replacing copyrighted map figures may be helpful: USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/ The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/ Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/ Landsat: http://landsat.visibleearth.nasa.gov/ USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/# Natural Earth (public domain): http://www.naturalearthdata.com/ 4. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The study addresses a critical gap in wildlife disease surveillance by implementing a useful and needed tool to survey wild animals passively. They highlight the urgency of this epidemiological surveillance system, with an extensive pathological work paired with a broad literature review on the topic. The authors show the relevance of such approach with significant examples such as the circulation of Canine Distemper Virus, which could potentially be a treat for wildlife and domestic dogs. However, although the authors state that they aim “to evaluate the technical and infrastructural feasibility to establish” a passive surveillance system, they are only demonstrating the feasibility of this approach by describing in detail they pathological findings and discussing the relevance of their results for public health and conservation, without any further analysis or clear evaluation of viability of their program. The information their research provided is however, of great value, and the authors make a strong case of the need of such passive surveillance in a low-resource country like Costa Rica. They showed they have the infrastructural and expertise to carry this surveillance program, but probably lack the financial and logistical support to make this program permanent. However, they don’t seem to propose a protocol or guidelines on how to make this program available and reproducible in the country (including the sites they identify as under-studied) and other regions. For instance, they could address aspects such as that most of their samples came from wildlife rescue center as possible ways of improving and sustaining their surveillance program. In line 278-280 they even mentioned that they encounter obstacles, but do not mention how those obstacles were overcome. I suggest they proposed clearer steps moving forward, if they truly want to evaluate the implementation of this valuable wildlife surveillance program. The text has some grammatical errors and redundant sentences, that makes the reading hard to follow. I mention some of these issues below, in addition to other observations. Lines 50-53. Covid-19 would not make a good example. Although it may have a zoonotic origin, it is considered a human-to-human disease. May be consider another example. Lines 54-56. These two sentences seem redundant. Consider rephrasing. Line 59. Consider changing “countries” for “regions”, and eliminating the “(including Costa Rica)” Line 61. Consider changing “geographic regions” for “countries” Line 64. Do you mean increased land use change? Lines 76-77. In that case, since they are post-mortem examinations, it would not be morbidity, right? Line 77-79. I don’t follow this sentence. What do you mean by “obtaining a sustainable tool that allows understanding the emerging potential of different pathogens.”? Also, consider changing “profitability” to “cost-effective” because the latter has a connotation of lucrative. Line 88. A disease is not a synonym for pathogen, please change “vector-borne diseases” accordingly. Lines 89-93 and 96-98. Please rephrase these sentences, as they are unclear and hard to follow. Lines 99-101. Avoid giving specific results here (e.g., 85 carcasses), just general and main findings. Line 108. Isn’t the permit R-SINAC-PNI-ACLAC-039 for the Area de Conservacion La Amistad Caribe only? Table 1. superscript b. Cloacal swab is not a tissue, please change accordingly. Lines 167-168. Please change “specimens of the birds and 76 (89.5%) of the mammals” to “bird and 76 (89.5%) mammal specimens” Lines 170-173. This information doesn’t seem to belong in this subsection but rather in either of the following ones. Lines 178-181. 24 + 3 + 1 + 4 = 32, not 31 as stated below. Please check this. Also, please be specific on what are you referring to with “parasites”. Lines 184-193. I am confused with this whole paragraph and the data presented below (including in Table 2). I imagine that you have several tissue samples from the same carcass, because you had 85 individuals total, but are now presenting 266 lesions total (199 + 67). Please clarify. Lines 195-196. 11 + 5 + 4 = 20, it doesn’t add to 21. Please check this. Lines 199-200. Do you mean that the rest of the tissues with infection lesions were associated with a pathogen? And what is the complementary analysis? Table 2. I suggest you change “Bird” for “Aves”, to keep the correct taxa name for all the groups sampled. Lines 241-242. Do you mean in here that all the birds, total of nine, were screened for viruses? From which, only the two that were involved in a mass mortality event were positive for flaviviruses? Please rephrase accordingly. Line 300. Rephrase to: Regarding mammals, carnivores and primates were the taxa with higher representation Lines 302-304. It is unclear what do you mean with this sentence. Are you suggesting that human proximity makes transmission of this infectious agents more common, or that the sole proximity facilitates pathogen detection? Also, it could be possible that cases of more charismatic animals are over-represented. Lines 305-306. Anthropogenic effect it’s a broad term. Can you rephrase and be more specific? Lines 313-315. What do you mean by human conditions? Also, I am not sure if you are using the term “evolve” correctly here. Do you mean pathogen evolution or how the disease develops? Lines 331-332. This sentence is very vague. Please rephrase and be more specific. Line 335. Please change “(CoastLine)” to “by the coast”. Lines 336-340. What about conservation implications? What if this pathogen detection reveals the transmission of pathogens from domestic animals to wildlife? Line 349 (and others) Please be consistent with the naming. If you used “CDV” at the beginning after explaining what it stands for, you should keep using the same name. Also, include the genus information at the beginning, where you mentioned the pathogens you are going to be screening for. Line 353. Please change “studies” to “study”. Lines 355-356. Can you provide a reference for this estimation? Line 363. With “productive animal” do you mean livestock? Line 379. Replace “the Nasua narica species” to “Nasua narica” Figure 3. Giving that you mentioned that samples are biased toward the wildlife management centers, it would be informative to show in the map the location of the centers that sent the carcasses. If there is no clear purpose for the color coding on the map (I imagine indicating elevation), I suggest removing it, because it makes the figure harder to interpret. Finally, consider using other type of icons to show the pathogens detected that are not 3D. Figure S1. This map was very noisy and hard to interpret. Consider simplifying as much as possible. May be to order, instead of genus, and removing the elevation color. Please check your references. Scientific names should be in italics and there are a few mistakes, such as in Line 534, where Panama and Costa Rica are not capitalized. Reviewer #2: Initially I would like to congratulate Dr. Alfaro-Alarcon for this manuscript, we know that research efforts to develop studies like the one presented here require a network of motivated institutions and people, this can be evidenced in this manuscript. So please feel proud of this manuscript fruit of his continuous work for almost three years. Congratulations. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: PEDRO ENRIQUE NAVAS SUÁREZ [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-21-39637R1Passive epidemiological surveillance in wildlife in Costa Rica identifies pathogens of zoonotic and conservation importancePLOS ONE Dear Dr. Alfaro-Alarcon, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Both reviewers agree that this version of the manuscript is improved, but the authors should strongly consider the points outlined below to make their suggestions on implementing a wildlife parasite surveillance system more generalizable. Please submit your revised manuscript by Aug 12 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Daniel Becker Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: No Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #2: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors present a tool of passive surveillance that is both cost-effective and essential to monitor wildlife health and potential risk of spillover and spillback events. With their results, they demonstrate that despite the challenges developing countries face, there is a need to stay vigilant, as pathogens like Canine Distemper Virus and zoonotic gastrointestinal parasites were detected in their study. They also show and discuss important research gaps, such as the lack of information from certain areas in the country due to lack of resources and remoteness, and the misrepresentation of birds in their surveillance program. In their first submission, the authors only presented their results without proposing a feasible and standardized method to implement this tool. In this version, they provide more detail (exemplified in figure 1), but I am afraid that their suggestions are very country specific. If this manuscript is accepted, I suggest that it would be under the study type “Methods, software, databases, and tools”, which should meet the criteria of utility, validation and availability (see https://journals.plos.org/plosone/s/submission-guidelines#loc-methods-software-databases-and-tools), and should be developed more broadly to propose a scheme for other countries with similar challenges. Although, their epidemiological findings are interesting by themself, they are not the real focus of the paper, but rather are the evidence to stress the need to implement their proposed passive surveillance program in a sustainable manner with the tools that are already available. However, it seems like the authors shift the focus of their paper in presenting their findings. As an example, tables 3, 4 and 5 could be supplemental materials. Finally, I found the manuscript difficult to follow. Occasionally, the sentences read awkward (e.g., Lines 50-53), had typos (e.g., Line 55) or wrong terms (e.g., “academy” in Lines 312-314), were grammatically incorrect (e.g., Line 80-82 and Line 95-97), or lacked a clear structure (e.g., Lines 108-112). The authors should do some intense editing to their manuscript, with a more concise language, and, if available, consider asking for English-proof reading services. Reviewer #2: Dear authors, Initially, I want to express my good energies to you, for accepting the comments made and implementing them in an appropriate way in the manuscript. I confess that the manuscript with the modifications made is much clearer and meets the proposed objectives. A few comments below. 1. I recommend the use the following categories: metazoan parasites, protozoan parasites. 2. Please, double check the grammar of the text, mainly in the introduction, in general the English could be a little more fluent. However, I emphasize that this does not affect at all the understanding of the ideas they expose. Minor comments: Line 5: delete of (repeated) Line 197: change pulmonary parasitic worms to lungworm. Table 4: change parasitic worms to metazoan parasites. For my part, I have no further comments, I believe that this manuscript will be of great importance to show feasible examples of disease surveillance in wildlife in Latin America. Once again congratulations Dr. Alfaro and coatures. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Pedro Enrique Navas-Suárez ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
PONE-D-21-39637R2Passive epidemiological surveillance in wildlife in Costa Rica identifies pathogens of zoonotic and conservation importancePLOS ONE Dear Dr. Alfaro-Alarcon, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 14 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Daniel Becker Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I want to congratulate the authors, not just for the relevance of their paper and the amount of work they did with the implementation of the passive surveillance, but also for the great improvement they made to present their findings, implications and recommendations. I just have a few very minor comments that will be easily corrected. L34-36: “For instance, 60% (51/85) of the deaths were not associated with an infectious agent. In 67.4% (32/85) of the cases, deaths were not associated with an infectious agent, but an infectious agent was detected.” These two sentences seem to be repeating the statement, and there seems to be a mistake: 32/85 is 37.6%, not 67.4%. Please check this. Same error in L191. L37: The acronym “WHMP” is mentioned here, without first stating what does it stand for. L84: Consider removing the acronym “LMIC” since it is not used in the rest of the paper, and it is confusing. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 3 |
|
Passive epidemiological surveillance in wildlife in Costa Rica identifies pathogens of zoonotic and conservation importance PONE-D-21-39637R3 Dear Dr. Alfaro-Alarcon, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Daniel Becker Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-39637R3 Passive epidemiological surveillance in wildlife in Costa Rica identifies pathogens of zoonotic and conservation importance Dear Dr. Alfaro-Alarcón: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Daniel Becker Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .